Skip to main content
Boryung Pharma to market blood pressure combo drugs in Southeast Asia
10/11/2017

South Korean drugmaker Boryung Pharmaceutical reached an agreement with Zuellig Pharma distributor Zanovex to sell its anti-hypertensive combination drugs Dukarb, or fimasartan/amlodipine, and Tuvero, or fimasartan/rosuvastatin, in Southeast Asian countries.

Full Story: